临床 试验
- Study of Platinum Plus Etoposide With or Without BGB-A317 in Patients With Untreated Extensive-Stage Small Cell Lung Cancer条件:肺癌分子:Tislelizumab
- Study of Tislelizumab (BGB-A317) Versus Placebo in Combination With Chemoradiotherapy in Patient With ESCC条件:食道癌分子:Tislelizumab
- Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Patients With Urothelial Carcinoma条件:膀胱癌分子:Tislelizumab
- Study of Tislelizumab (BGB-A317) in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer条件:膀胱癌分子:Tislelizumab
- A Study to Investigate Sitravatinib as Monotherapy and in Combination With Tislelizumab in Patients With Unresectable Locally Advanced or Metastatic HCC or GC/GEJC条件:肝癌分子:Tislelizumab
- Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer条件:分子:Tislelizumab
- Study of the Safety and Pharmacokinetics of BGB-283 and PD-0325901 in Patients With Advanced or Refractory Solid Tumors条件:晚期实体肿瘤分子:Lifirafenib
- A Study of ME-401 in Subjects With CLL/SLL, FL, and B-cell Non Hodgkin's Lymphoma条件:淋巴瘤分子:Zanubrutinib
- Study of Zanubrutinib (BGB-3111) in Patients With Marginal Zone Lymphoma条件:淋巴瘤分子:Zanubrutinib
- Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma条件:胃癌, 食道癌分子:Tislelizumab